Slow and steady wins the race: Optimizing lentiviral vector production for efficient clinical-scale manufacturing

被引:0
|
作者
Mccarron, Alexandra [1 ,2 ,3 ]
机构
[1] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[2] Womens & Childrens Hosp, Dept Resp & Sleep Med, North Adelaide, SA, Australia
[3] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
关键词
D O I
10.1016/j.omtm.2023.08.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:484 / 485
页数:2
相关论文
共 12 条
  • [1] Clinical-Scale Production of Lentiviral Vectors at a New Academic cGMP Facility
    Moncada, Cesar
    Liermann, Andrew
    Lewis, Charles
    Medin, Jeffery
    McKillop, William M.
    MOLECULAR THERAPY, 2023, 31 (04) : 391 - 392
  • [2] OPTIMIZING LENTIVIRAL VECTOR PRODUCTION FOR CELL THERAPIES: ADVANCING MANUFACTURING STRATEGIES AT OMNIABIO
    Al Asafen, H.
    Sudarsan, A. K.
    Mcleod, A.
    Kawka, K.
    Maystrenko, A.
    Sirskyj, D.
    Bagheri, M.
    Attignon, E.
    Chettiar, D.
    Beaudette, P.
    Razvi, A.
    Patel, N.
    McNally, K.
    Gacerez, A.
    Fardy, M.
    CYTOTHERAPY, 2024, 26 (06) : E29 - E30
  • [3] Clinical-scale Lentiviral Vector Transduction of PBL for TCR Gene Therapy and Potential for Expression in Less-differentiated Cells
    Yang, Shicheng
    Rosenberg, Steven A.
    Morgan, Richard A.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 830 - 839
  • [4] Translation of small-scale CAR-T cell manufacturing methods to a clinical-scale production platform
    Koylijarvi, M.
    Skirdenko, V.
    Puttonen, K.
    Koponen, T.
    Pietikainen, S.
    Bailey, A.
    Gurvich, O.
    Schenkwein, D.
    Yla-Herttuala, S.
    Kailaanmaki, A.
    Kekarainen, T.
    CYTOTHERAPY, 2020, 22 (05) : S127 - S128
  • [5] Slow and Steady Wins the Race: A Randomized Clinical Trial of Acceptance and Commitment Therapy Targeting Shame in Substance Use Disorders
    Luoma, Jason B.
    Kohlenberg, Barbara S.
    Hayes, Steven C.
    Fletcher, Lindsay
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2012, 80 (01) : 43 - 53
  • [6] Large-Scale Production of Clinical Grade Lentiviral Vector in a Closed System Hollow Fiber Bioreactor
    Sheu, Jonathan
    Fury, Brian
    Tobin, Steve
    Falconer, Danny
    Beltzer, Jim
    Bauer, Gerhard
    MOLECULAR THERAPY, 2014, 22 : S281 - S282
  • [7] Scaling up the Lentiviral Vector Manufacturing Using iCELLis500 Clinical Scale Fixed-Bed Bioreactor
    Lipponen, Eevi M.
    Leinonen, Hanna M.
    Oruetxebarria, Igor
    Valkama, Anniina J.
    Malinen, Joonas
    Turkki, Vesa
    Laaksonen, Iina
    Pietikainen, Sanna
    Kayhty, Piia
    Heikura, Tommi
    Yla-Herttuala, Seppo
    Lesch, Hanna P.
    MOLECULAR THERAPY, 2017, 25 (05) : 224 - 224
  • [8] Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
    Cheryl L-L Chiang
    Dawn A Maier
    Lana E Kandalaft
    Andrea L Brennan
    Evripidis Lanitis
    Qunrui Ye
    Bruce L Levine
    Brian J Czerniecki
    Daniel J Powell Jr
    George Coukos
    Journal of Translational Medicine, 9
  • [9] Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
    Chiang, Cheryl L-L
    Maier, Dawn A.
    Kandalaft, Lana E.
    Brennan, Andrea L.
    Lanitis, Evripidis
    Ye, Qunrui
    Levine, Bruce L.
    Czerniecki, Brian J.
    Powell, Daniel J., Jr.
    Coukos, George
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [10] Clinical-Scale Production and Characterization of Ntla-5001-a Novel Approach to Manufacturing CRISPR/Cas9 Engineered T Cell Therapies
    Cossette, Daniel
    Aiyer, Shloka
    Kimball, Casey
    Luby, Chris
    Zarate, Jason
    Eng, Justin
    Doshi, Vinita
    Cole, Riley
    Kolluri, Nikunja
    Jaligama, Shreelekha
    Gardner, Noah
    Wood, Kristy
    Clark, Eliana
    BLOOD, 2021, 138